Palvella Therapeutics, Inc. (PVLA) vs Septerna, Inc. (SEPN)
- Palvella Therapeutics, Inc. PVLA 120.30 −5.53%
- Septerna, Inc. SEPN 36.05 −3.74%
Palvella Therapeutics, Inc. and Septerna, Inc. are both Biotechnology companies. Palvella Therapeutics, Inc. and Septerna, Inc. are of similar size ($1.8B and $1.8B). Septerna, Inc. grew revenue faster over the last twelve months: 13,520.1% against 146.7%. Palvella Therapeutics, Inc. has the higher net margin (0.00% vs −24.5%) and the higher return on invested capital (0.00% vs −189.0%). Across the 15 metrics below, Septerna, Inc. leads on 10 and Palvella Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | PVLA | SEPN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (44.04%) | 0.00% |
| Net margin | 0.00% | (24.51%) | 0.00% |
| Free cash flow margin | 0.00% | 118.93% | 0.00% |
| Return on equity | (46.63%) | (6.34%) | (56.36%) |
| Return on assets | (37.70%) | (4.94%) | (48.04%) |
| Return on invested capital | 0.00% | (189.01%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack